Quest Diagnostics has seen its Fair Value Estimate rise slightly, climbing from $188.19 to $191.56 per share as analysts factor in updated growth expectations. This change is supported by increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback